Human Urinary Bladder Transitional Cell Carcinomas Acquire the Functional Fas Ligand during Tumor Progression
- 1 April 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 162 (4) , 1139-1149
- https://doi.org/10.1016/s0002-9440(10)63910-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Transitional cell carcinoma expresses high levels of Fas ligand in vivoBJU International, 1999
- Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.Journal of Clinical Investigation, 1998
- Failure of TGF β1 and IL‐12 to regulate human FasL and mTNF alloreactive cytotoxic T‐cell pathwaysTissue Antigens, 1998
- Clonality of Tumor-Infiltrating Lymphocytes in Human Urinary Bladder CarcinomaJournal of Immunotherapy, 1997
- Expression and functions of EGF FGF and TGFβ-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cellsInternational Journal of Cancer, 1997
- Introduction: The molecular regulation of lymphocyte apoptosisSeminars in Immunology, 1997
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- Expression of mage genes in transitional‐cell carcinomas of the urinary bladderInternational Journal of Cancer, 1995
- Production of stable cytolytic T‐cell clones directed against autologous human melanomaInternational Journal of Cancer, 1987
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983